PDS Biotechnology Corporation
PDSB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $42 | $57 | $74 | $65 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $3 | $2 | $3 | $2 |
| Total Curr. Assets | $45 | $59 | $76 | $67 |
| Property Plant & Equip (Net) | $0 | $0 | $1 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $0 | $0 | $1 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $45 | $59 | $77 | $67 |
| Liabilities | – | – | – | – |
| Payables | $2 | $7 | $1 | $1 |
| Short-Term Debt | $13 | $4 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $3 | $2 | $8 | $2 |
| Total Curr. Liab. | $17 | $14 | $10 | $4 |
| LT Debt | $9 | $20 | $23 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $9 | $20 | $23 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $26 | $33 | $33 | $4 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$182 | -$145 | -$102 | -$61 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $201 | $171 | $146 | $124 |
| Total Equity | $19 | $26 | $44 | $63 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $45 | $59 | $77 | $67 |
| Net Debt | -$20 | -$33 | -$50 | -$65 |